New Light-Based scanner could tell cancer from benign moles in seconds

NCT ID NCT07201376

Recruiting now Diagnosis Sponsor: Dartmouth-Hitchcock Medical Center Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 31 times

Summary

This study is testing a new, non-invasive device called a tissue oxygen imager. It uses a special light and a cream (ALA) to measure oxygen levels in skin growths. Cancerous areas have low oxygen, which the imager can detect. The goal is to see if this method can accurately tell the difference between non-melanoma skin cancer and harmless skin growths without needing a biopsy. The study will enroll 125 adults who already have a skin cancer diagnosis and are scheduled for surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-MELANOMA SKIN CANCER (NMSC) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Dartmouth Hitchcock
RECRUITING

Lebanon, New Hampshire, 03766, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

BENIGN SKIN GROWTH NON-MELANOMA SKIN CANCER (NMSC) NON-MELANOMA SKIN CANCER (NMSC)